Dysregulated high-density lipoprotein and low-density lipoprotein subfractions increase metabolic dysfunction-associated steatotic liver disease risk: A study of patients across body mass index categories

Accession: MTBLS13821
Source / host: MetaboLights — EBI MetaboLights FTP
Disease relevance: MASLD / NAFLD / NASH (category: Metabolomic, subtype: metabolomics/lipidomics)
Modality / assay: metabolomics
Platform: metabolite profiling assay; NMR spectroscopy assay; Nuclear Magnetic Resonance (NMR) -
Organism: unspec
Size (indexed): 1.4 GB (1474870675 bytes)
Downloaded bytes: 458.0 KB (468980 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
a_MTBLS13821_NMR___metabolite_profiling.txt300.2 KBe3e1526150b41914…
i_Investigation.txt14.1 KB1b3ccf24ad9462da…
m_MTBLS13821_NMR___metabolite_profiling_v2_maf.tsv16.3 KBa85cd2599de9c081…
s_MTBLS13821.txt127.4 KB75c1e27b5a60b4be…

Index note: public study (ISA-Tab+MAF)

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T19:29:31Z.

About this dataset

This metabolite profiling assay; NMR spectroscopy assay; Nuclear Magnetic Resonance (NMR) - dataset provides single-cell gene expression from unspec liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.